| 标题 |
Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of oncology : official journal of the European Society for Medical Oncology 作者:Felip E; Cho BC; Gutiérrez V; Alip A; Besse B; et al 出版日期:2024/09/01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)